Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Phil Gutis
Phil’s Journal: An IRL Example of Racism’s Affects on Cognition
Phil’s Journal: Making Space for the Layperson at Scientific Conferences
Phil’s Journal: Exercise Protects the Brain From MCI, But…
Phil’s Journal: An Alzheimer’s Story In LEGOs
Phil’s Journal: Reflections on AAIC, Day One
Alzheimer’s Blood Tests Take Another Step Forward
Phil’s Journal: Bringing the Patient’s Perspective to AAIC
Phil’s Journal: The Face of Alzheimer’s Is Changing — Are We Ready?
Phil’s Journal: What’s Next for the Aducanumab Clinical Trial Rollercoaster?
Alzheimer’s Association All In On Not-Yet-Approved Aducanumab
Phil’s Journal: A Lesson on Living With Alzheimer’s, Courtesy of My Dog
‘The Problem of Alzheimer’s’ Makes Us Mad—In a Good Way
Cassava’s Simufilam: Who to Believe—Wall Street or Alzheimer’s Researchers?
FDA Delays Aducanumab Decision
Phil’s Journal: Reflections on Alzheimer’s Drug Aducanumab’s Latest Snag
Previous
1
2
3
Next
Page load link
Go to Top